Presidio Pharmaceuticals Receives $6,000,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ad67ca36-a755-4ab5-bc87-56c722815d41&Preview=1
Date
12/21/2011
Company Name
Presidio Pharmaceuticals
Mailing Address
1700 Owens Street San Francisco, CA 94158
Company Description
Presidio is focused on developing novel and established therapeutic modalities and small molecule compounds for the treatment of HIV-1, HCV and other chronic virus infections.
Website
http://www.presidiopharma.com
Transaction Type
Debt, Venture Equity
Transaction Amount
$6,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed